Verana Health announced the appointment of Matthew Roe, MD, MHS, as Chief Medical Officer. A cardiologist and clinical researcher, Dr. Roe joins Verana Health after spending over 2 decades at the Duke University School of Medicine and the Duke Clinical Research Institute (DCRI), the world’s largest academic clinical research organization. At Duke, he focused on research initiatives leveraging real-world data and patient engagement.
“Dr. Roe is an acclaimed physician-scientist with over two decades of experience focused on the intersection of patient care and real-world data; a complete alignment with the clinical efforts of Verana Health,” Miki Kapoor, CEO of Verana Health, said in a company news release. “As a physician and researcher, Matt’s focus has been on developing and testing different ways technology and real-world data can be combined to transform clinical research. We are thrilled to bring his extraordinary knowledge to our team and further accelerate the use and applications of real-world data in scientifically rigorous approaches to generate real-world evidence for the healthcare ecosystem.”
As Chief Medical Officer, Dr. Roe will lead Verana’s medical and data science teams working to ensure the clinical validity and scientific integrity of its research. He will also work closely with regulatory agencies and the medical/scientific community, focusing on data quality while also expanding the applications of regulatory-grade data that are being developed from Verana’s data partnerships.
“Verana has built trusted relationships with some of the largest medical associations in the country,” said Dr. Roe. “These collaborations put us in a unique position to connect real-world data across sources, types, time, and scale to create a more complete view of human health and the patient journey. I’m excited to bring my experience to this incredible team to further realize the ways real-world data can enable the clinician-patient relationship and improve the health of patients across diverse medical conditions.”
Dr. Roe was previously a co-principal investigator for the ADAPTABLE trial — highlighted by the FDA as a successful example of a real-world data study in their framework for real-world evidence guidelines. He also led several observational registries with a focus on the treatment and outcomes of patients with cardiovascular disease. At the DCRI — known for its trailblazing approaches in the real-world evidence space — Dr. Roe served as Senior Investigator as well as the Director of the organization’s Clinical Research Fellowship and “Think Tank” series between 2010 and 2019.
Dr. Roe received his MD and MHS degrees from Duke University School of Medicine in 1993 and 2001, respectively. He completed an Internal Medicine residency at Duke University Medical Center in 1996 and a Cardiovascular Fellowship at the Cleveland Clinic Foundation in 1999.